Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — August 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.7k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bibob
    wrote on sidst redigeret af
    #1455

    Biotech Giant Amgen could be nearing a massive takeover: report. ( investors business Daily ). https://www.investors.com/news/technology/biotech-company-amgen-could-near-deal-acquire-alexion-pharma/

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bibob
      wrote on sidst redigeret af
      #1456

      God morgen. :-).

      1 Reply Last reply
      0
      • T Offline
        T Offline
        transalp
        wrote on sidst redigeret af
        #1457

        Go morgen... 🙂

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #1458

          Sorry Jedi. Havde ikke set dit link i aftes. 😉

          1 Reply Last reply
          0
          • J Offline
            J Offline
            Jedi
            wrote on sidst redigeret af
            #1459

            Godmorgen 🙂 no worries Bibob - hellere poste en gang ekstra end at det slet ikke kommer på chatten 🙂

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #1460

              Hvis det havde været Genmab der var målet var ATH fortid 5 min. efter åbning. 😉

              1 Reply Last reply
              0
              • J Offline
                J Offline
                Jedi
                wrote on sidst redigeret af
                #1461

                Ja, det er store summer der er i spil - ALXN har vel en market cap på over det dobbelte af GEN

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  Jedi
                  wrote on sidst redigeret af
                  #1462

                  men stadig kun rygter - nok også derfor ALXN "kun" steg 7,5% i går

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Plimsoller
                    wrote on sidst redigeret af
                    #1463

                    Helst ingen bud på Genmab før vi er i kurs 2000 🙂

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #1464

                      Tak for link Jedi og bibob. Bestemt interessant og lad os da bare få et bud på Genmab. Det vil kun øge interessen endnu mere og skubbe kursen frem. Om man så vil sige ja eller nej, må jo afhænge af et eventuelt buds størrelse;-)

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #1465

                        se bare hvad der sandsynligvis sker om en halv times tid med B&O aktien https://borsen.dk/nyheder/virksomheder/artikel/1/386522/investeringsoekonom_udmelding_fra_ole_andersen_kan_give_kursstigninger_til_bang_olufsen-aktien.html

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #1466

                          Blood journal - Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
                          -by Saad Z. Usmani
                          http://www.bloodjournal.org/content/134/8/668?sso-checked=true

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #1467

                            GSK2857916) on track for regulatory submission by the end of 2019 https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-headline-results-from-the-pivotal-dreamm-2-study-for-multiple-myeloma/

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #1468

                              New trial in Korea Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma (Dara_DCEP) https://www.clinicaltrials.gov/ct2/show/NCT04065308?term=daratumumab+OR+ofatumumab+OR+arzerra+OR+darzalex+OR+tisotumab+OR+Genmab&lupd_s=08%2F22%2F2019&rank=2

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #1469

                                Multiple myeloma is not confined to a specific bone or location within a bone. It tends to involve the entire skeleton. When only one lesion is found it is called a “plasmacytoma.” Most doctors believe that plasmacytoma is simply an early, isolated form of multiple myeloma.

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1470

                                  New trial in Israel - Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients (KyDaR) - https://www.clinicaltrials.gov/ct2/show/NCT04065789?term=daratumumab+OR+ofatumumab+OR+arzerra+OR+darzalex+OR+tisotumab+OR+Genmab&lupd_s=08%2F22%2F2019&rank=4

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #1471

                                    Impressive planning for GSK2857916 - a lot head to head studies

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #1472

                                      yes, maybe they learned from their Ofatumumab f*** up....

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #1473

                                        Bergenbio oppe med 25% og stigende.

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #1474

                                          30%

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger